Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
Submitted by
admin
on February 17, 2010 - 9:01am
Source:
WSJ Online
News Tags:
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Headline:
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
Do Not Allow Advertisers to Use My Personal information
